Posts by: Forest Ray PhD

Forest Ray PhD

Forest Ray received his PhD in systems biology from Columbia University, where he developed tools to match drug side effects to other diseases. He has since worked as a journalist and science writer, covering topics from rare diseases to the intersection between environmental science and social justice. He currently lives in Long Beach, California.

March 31, 2021March 31, 2021

Interim Results of CMT&Me Study Presented in Webinar

News

Depression, hand-and-finger weakness, and a lengthy delay from symptoms to diagnosis contribute to the burdens felt by people living with Charcot-Marie-Tooth disease (CMT). Those are among the key findings of ... Read more

March 2, 2021March 2, 2021

CMT Prevalence in Denmark May Be 16% Higher Than Estimates

News

The true prevalence of Charcot-Marie-Tooth disease (CMT) in Denmark may be higher than previously thought, according to a recent Danish study in which researchers applied diagnostic criteria for CMT to ... Read more

February 12, 2021February 12, 2021

Mutations in LRSAM1 Gene Tied to Rare CMT Subtype

News

Mutations in the LRSAM1 gene result in the rare, type 2P subtype of Charcot-Marie-Tooth disease, but the location of such mutations within the gene appears to influence the inheritance pattern and possibly ... Read more

January 28, 2021January 28, 2021

COVID-19 Vaccines Pose Little Risk to Rare Disease Patients, FDA, CDC Say

News, syndicated

The two COVID-19 vaccines that recently received emergency approval from the U.S. and other worldwide regulatory agencies are expected to pose little risk to the rare disease community, including to ... Read more

January 22, 2021January 22, 2021

Research Ongoing Into Newly Identified Subtype Tied to SORD Gene

News

Researchers are investigating whether treatments for other disorders might benefit people with a newly identified type of Charcot-Marie-Tooth disease (CMT) that may be a common recessive form of hereditary neuropathy. ... Read more

January 12, 2021January 12, 2021

Pregnancy Can Worsen CMT Symptoms With Outcomes Unaffected, Italian Study Finds

News

Charcot-Marie-Tooth disease (CMT) does not significantly affect the outcomes of pregnancies but a pregnancy can cause CMT symptoms to worsen, according to a study in Italy, which also recommends that ... Read more

December 11, 2020December 11, 2020

Survey Seeks to Assess Impact of Medications on CMT Symptoms

News

A group of researchers is inviting adult Charcot-Marie-Tooth disease (CMT) patients who have mobility or dexterity limitations and/or their caregivers to take an online survey regarding their experiences using medicines. ... Read more

December 4, 2020December 4, 2020

Japanese Study: New MPZ Gene Variants Tied to Diverse CMT Symptoms, Features

News

People with Charcot-Marie-Tooth (CMT) and mutations in the MPZ gene have highly variable disease symptoms, according to a recent Japanese study, which found that these patients may be diagnosed with ... Read more

November 17, 2020November 17, 2020

Drug Screen Finds Dozens of Potential Therapeutic Compounds for CMT2A

News

AcuraStem has identified 37 compounds that improve nerve cell survival and might help treat Charcot-Marie-Tooth disease type 2A (CMT2A), according to a press release from the CMT Research Foundation. CMT2 accounts ... Read more

November 10, 2020November 10, 2020

App-based Study Seeks Real-world Data on the Personal Impact of CMT

News

An international observational study using a smartphone-based app called CMT&Me is exploring the impact of Charcot-Marie-Tooth disease (CMT) on patients and caregivers. The study (NCT03782883) was designed by Vitaccess in collaboration with Pharnext. ... Read more